Previous reports in other cancer types, notably ovarian cancer, have consistently demonstrated that SFXN1 plays a pivotal role in supporting tumor growth, metabolic regulation, and mitochondrial function. This evidence concerns the gene SFXN1 and ovarian carcinoma.